Search

Your search keyword '"Nantermet, Philippe G."' showing total 135 results

Search Constraints

Start Over You searched for: Author "Nantermet, Philippe G." Remove constraint Author: "Nantermet, Philippe G."
135 results on '"Nantermet, Philippe G."'

Search Results

1. To Market, to Market—2018: Small Molecules

4. Addition of zinc homoenoates to acetylenic esters and amides: a formal (3 + 2) cycloaddition

6. Synthesis of Complex Druglike Molecules by the Use of Highly Functionalized Bench-Stable Organozinc Reagents

8. Discovery of MK-8718, an HIV Protease Inhibitor Containing a Novel Morpholine Aspartate Binding Group

10. SAR of tertiary carbinamine derived BACE1 inhibitors: Role of aspartate ligand amine p Ka in enzyme inhibition

12. Modeling a Crowdsourced Definition of Molecular Complexity

13. Total synthesis of (+/-)-ginkgolide

14. Synthesis of novel taxoids

15. Strategies towards Improving the Pharmacokinetic Profile of ε‐Substituted Lysinol‐Derived HIV Protease Inhibitors

16. Stroke Therapy

18. SAR of tertiary carbinamine derived BACE1 inhibitors: Role of aspartate ligand amine pKa in enzyme inhibition

19. Evolution of Tertiary Carbinamine BACE‐1 Inhibitors: Aβ Reduction in Rhesus CSF upon Oral Dosing

21. Design, synthesis, and SAR of macrocyclic tertiary carbinamine BACE-1 inhibitors

22. Discovery and SAR of isonicotinamide BACE-1 inhibitors that bind β-secretase in a N-terminal 10s-loop down conformation

26. Discovery of Oxadiazoyl Tertiary Carbinamine Inhibitors of β-Secretase (BACE-1)

27. P2 pyridine N-oxide thrombin inhibitors: a novel peptidomimetic scaffold

28. 9-Hydroxyazafluorenes and Their Use in Thrombin Inhibitors

30. Discovery and Evaluation of Potent P1 Aryl Heterocycle-Based Thrombin Inhibitors

31. Imidazole acetic acid TAFIa inhibitors: SAR studies centered around the basic P 1 ′ group

33. Synthesis and Evaluation of Imidazole Acetic Acid Inhibitors of Activated Thrombin-Activatable Fibrinolysis Inhibitor as Novel Antithrombotics

34. Unexpected enhancement of thrombin inhibitor potency with o -aminoalkylbenzylamides in the P1 position

35. Pharmacokinetic optimization of 3-amino-6-chloropyrazinone acetamide thrombin inhibitors. implementation of P3 pyridine N-Oxides to deliver an orally bioavailable series containing P1 N-Benzylamides

38. Discovery of a nonpeptidic small molecule antagonist of the human platelet thrombin receptor (PAR-1)

39. Discovery and initial structure–Activity relationships of trisubstituted ureas as thrombin receptor (PAR-1) antagonists

41. The total synthesis of (+)-Ginkgolide

43. The Total Synthesis of (±)-Ginkgolide B

44. Selective α1a adrenergic receptor antagonists based on 4-aryl-3,4-dihydropyridine-2-ones

45. In Vitro and in Vivo Evaluation of Dihydropyrimidinone C-5 Amides as Potent and Selective α1A Receptor Antagonists for the Treatment of Benign Prostatic Hyperplasia

47. Total Synthesis of (±)-Ginkgolide B

48. P 2 pyridine N-oxide thrombin inhibitors: a novel peptidomimetic scaffold

Catalog

Books, media, physical & digital resources